Infertility is defined by the World Health Organization (WHO) as the inability to get pregnant over a one-year period of unprotected sexual intercourse \[[@r1]\]. Infertility represents a complex and multi-factorial condition affecting both males and females. Most of all, male infertility has been attracting increasing interest because of the decline in semen quality in young healthy men worldwide \[[@r1],[@r2],[@r3]\]. Many adverse factors affect sperm quality, including lifestyle, diabetes, obesity, hormonal diseases, testicular trauma, cryptorchidism, varicocele, genitourinary infections, ejaculatory disorders, chemo/radiotherapy, or surgical therapies \[[@r4],[@r5],[@r6]\]. It is well-known that genetic disorders of sperm are serious causes of male infertility, e.g., chromosomal abnormalities and gene mutations that cause a disorder of many physiological processes involved in hormonal homeostasis, spermatogenesis, and sperm quality \[[@r7], [@r8]\]. Sperm gene alterations of several sperm molecules associated with sperm-oocyte fusion on the sperm side were reported to induce infertility; these genetic problems include gene integrity, defective chromatin packaging, and a single-gene mutation. In this review, we tried to highlight those molecules participating in the sperm-oocyte fusion on the sperm side, which are mentioned in recent studies.

Sperm-oocyte Fusion is a Critical Step in Fertilization {#s1}
=======================================================

A series of well-orchestrated, highly complex sets of events must occur together in order for a spermatozoon to fertilize an oocyte. For complete fertilization, gametes (especially the sperm) should change their morphology, structure, and function. Sperm go through great transformation in the process of passage through the outside structure of the oocyte with the capacitation and the acrosome reaction changing its motility, physiology, and membrane structure ([Fig. 1](#fig_001){ref-type="fig"}Fig. 1.This diagram presents transformation of sperm morphology in terms of gamete fertility. After passing the cumulus cell layer, the acrosome-reacted sperm is capable of penetrating the zona pellucida and entering the perivitelline space. The equatorial segment of the acrosome-reacted sperm interacts with oocyte membrane and fusion begins. Finally, the sperm nucleus is released into the oocyte cytoplasm to accomplish fertilization.). It is widely believed that after sperm catches the egg, the acrosome reaction of the sperm is triggered by a component of the zona pellucida (ZP), an extracellular coat surrounding the oocyte. Nonetheless, recently, it was found that most fertilizing sperm began the acrosome reaction before reaching ZP \[[@r9]\]. In fact, the acrosome reaction is already observed in the female reproductive tract, especially at the ampulla \[[@r10]\]. After the acrosome reaction, the spermatozoa are able to penetrate the ZP and enter the perivitelline space. In the perivitelline space, the acrosomal structure of sperm disappears followed by the outer acrosomal membrane′s fusing with the overlying plasma membrane to generate the equatorial segment. The sperm-oocyte plasma membrane fusion has long been known to be initiated in the equatorial segment region \[[@r11]\]. Many proteins in the equatorial segment are reported to participate in the fusion process. Fertilization culminates together with sperm and oocyte finding each other, interacting, and fusing.

Sperm-oocyte fusion is a critical step in fertilization, which requires a series of proteins from both spermatozoa and oocyte to mediate membrane adhesion and subsequent fusion. Although the mechanisms and molecules in sperm-oocyte fusion on the sperm side are closely related to male infertility, little is still known about the mechanisms or the molecules involved \[[@r12]\]. In recent years, efforts have been made toward the identification of the molecular players and their function, and several molecules on the egg or the sperm side have been found to be essential or nearly essential \[[@r13]\]. Herein, this review mainly focuses on the factors implicated strongly in the sperm-egg fusion process on the sperm side to explain the potential mechanisms of male infertility.

IZUMO1 is Essential for Sperm-oocyte Fusion {#s2}
===========================================

The sperm protein IZUMO1 was first discovered through screening of anti-sperm monoclonal antibodies that disrupt the fusion process \[[@r14]\]. Using two-dimensional gel electrophoresis followed by liquid chromatography with tandem mass spectrometry, the antigen was named IZUMO \[[@r14]\]. Mouse IZUMO1 is an approximately 56-kDa protein that appears to be testis specific. *Izumo1*^−/−^ mice are healthy but males are infertile although they have normal mating behavior and ejaculation, and produce a normal vaginal plug \[[@r15]\]. *In vitro* fertilization (IVF) assays revealed that after penetration of the ZP, *Izumo1*-deficient sperm accumulate in the perivitelline space of the oocyte without fusion with oocyte membrane \[[@r15]\]. A knockout of IZUMO1 completely disrupts sperm fusion with an oocyte. There also appears to be an ortholog in humans because antibodies to the putative human IZUMO1 can react with an approximately 37-kDa protein in human sperm lysates, and the antibodies also inhibit fusion of human sperm to a ZP-free oocyte \[[@r15]\]. These results indicated that IZUMO1 is essential for sperm-oocyte fusion on the sperm side.

Furthermore, it was unexpectedly found that IZUMO1 is encoded as a transmembrane protein with an extracellular immunoglobulin-like domain, a single transmembrane region, and a short cytoplasmic tail, but without any fusogenic domain as in other fusion proteins \[[@r15]\]. Therefore, IZUMO1 is likely to combine with other surface proteins participating in the fusion process \[[@r11], [@r16]\]. It seems probable that IZUMO1 interacts with the associated proteins that directly facilitate the fusion process on the sperm membrane or on the oocyte membrane. Guided by this hypothesis, scientists found that IZUMO1 localization is affected by a testis-specific serine kinase encoded by *Tssk6*. In *Tssk6*-deficient sperm, IZUMO1 fails to be localized to the sperm equatorial segment after acrosome exocytosis \[[@r17]\]. Moreover, a knockout of *Tssk6* in sperm leads to the inability to fertilize an oocyte *in vitro* \[[@r17], [@r18]\]. Thus, the serine kinase Tssk6 mediates localization of IZUMO1 and interacts with IZUMO1 to participate in the sperm-oocyte fusion process. Recent evidence also revealed that an oocyte surface receptor named JUNO interacts with sperm IZUMO1 directly \[[@r19]\]. The oocytes of *Juno*-deficient mice are completely incapable of being fertilized by acrosome-reacted sperms. Disruption of the interaction should also inhibit the fusion process. Therefore, the interaction between IZUMO1 and Juno seems to be necessary for the adhesion process, thereby promoting the fusion process \[[@r19]\]. Most recently, a new molecular model of IZUMO1-JUNO recognition has been proposed where monomeric IZUMO1 binds JUNO and dimerizes quickly, then an unidentified receptor replaces JUNO to mediate membrane fusion \[[@r20]\]. Several studies revealed the crystal structures of human IZUMO1 and JUNO as well as the IZUMO1-JUNO complex \[[@r21],[@r22],[@r23],[@r24],[@r25]\]. The central β-hairpin region of IZUMO1 is crucial for integrity of JUNO′s binding surface located behind the putative JUNO ligand-binding pocket \[[@r22]\]. Therefore, it was proposed that the interaction of IZUMO1 with JUNO may act as a scaffold (before the beginning of membrane fusion) to juxtapose the two cell membranes in close proximity and to recruit other fusion proteins. Another study also showed that oocyte fusogen CD9 helps the JUNO receptor to interact with sperm IZUMO1 involved in the fusion process \[[@r26]\]. CD9 is well-known as a member of the tetraspanin family \[[@r27], [@r28]\]. *Cd9* knockout females were found to be severely subfertile: a breakthrough for the gamete interaction field \[[@r28], [@r29]\]. Taken together, these results proved that IZUMO1 is essential for sperm-oocyte fusion on the sperm side through complex mechanisms by interacting with other proteins either on the sperm membrane or on the oocyte membrane.

In addition, a recent study indicated that the short cytoplasmic tail of IZUMO1 is highly phosphorylated when it is located in the region from the head/tail region of sperm to the equatorial segment of sperm. In the caput regions of rat epididymis, there are only two phosphorylation sites in the cytoplasmic tail of IZUMO1. Nevertheless, when the sperm pass through the epididymis, the intracellular C-terminal tail of IZUMO1 is phosphorylated at seven sites \[[@r13]\]. In some infertile males, IZUMO1 is present in their sperm as its nonphosphorylated form or the number of phosphorylation sites is reduced compared with those in fertile men. Thus, it could be inferred that strong phosphorylation of IZUMO1 might play an important role in the IZUMO1 involvement in male infertility. Understanding this process requires more research.

A Disintegrin and Metalloprotease 2 (ADAM2) Plays a Role in Sperm-ZP Interaction {#s3}
================================================================================

Sperm ADAM2 was identified with a fertilization-blocking antibody and characterized as one of the members of a disintegrin and metalloprotease (ADAM) family \[[@r30], [@r31]\]. ADAMs are known as binding partners for several members of the integrin family \[[@r32]\]. A number of these integrins are expressed on the oocyte surface and perform important functions in sperm-oocyte interaction on the oocyte side. Thus, we will assume that ADAMs may participate in sperm-oocyte interaction via binding to integrins on the oocyte surface. This hypothesis puts specific ADAM-integrin pairs, especially ADAM2 and the integrin α9β1, in a category with abalone sperm lysin and oocyte VERL (vitelline envelope receptor for lysin) as cognate binding partners on the two gametes \[[@r33], [@r34]\]. Recent studies revealed that ADAM2 can enhance the initial adhesion of sperm to the oolema and increase the sperm attachment rate. The *Adam2*^--/--^ knockout also has severe defects in sperm membrane interactions and low expression level of several ADAM proteins on the sperm surface \[[@r35], [@r36]\]. Besides, the *Adam2*-deficient sperm show impaired migration into the oviduct through the uterotubal junction and fusion to the ZP and the oocyte plasma membrane \[[@r37]\]. Nonetheless, there needs to be more evidence to prove the hypothesis that ADAM2 has a function in the sperm-oocyte fusion through the interaction with the specific integrin on the oocyte membrane.

Sperm Equatorial Segment Protein 1 (SPESP1) is Crucial for Formation of the Equatorial Segment {#s4}
==============================================================================================

It is widely accepted that the equatorial segment after the sperm acrosome reaction is important for initiating the fusion with oocyte plasma membrane during fertilization \[[@r38]\]. There are various proteins known to be distributed only in the equatorial segment of sperm. The fusion-related proteins such as IZUMO1 should be localized to the sperm equatorial segment after acrosome endocytosis \[[@r3]\]. A number of sperm equatorial segment proteins (SPESPs) have also been studied regarding their roles in gamete membrane interaction. Among these, SPESP1 has been studied actively because either experiments with anti-SPESP1 antibodies or *in vitro* assay of *Spesp1* knockout mice resulted in severe inhibition of the sperm-oocyte fusion \[[@r39],[@r40],[@r41],[@r42]\]. The sperm equatorial segment can be disrupted completely due to the lack of SPESP1 in *Spesp1-*deficient males. Furthermore, the disruption of *Spesp1* was shown to induce an aberrant distribution of various sperm proteins, such as ADAM family proteins and MN9 antigen, which were found to participate in the fusion process \[[@r32], [@r42]\]. It has been proposed that SPESP1 may help to restrain the MN9 antigen at the moment of fusion \[[@r42]\]. SPESP1 can interact with these proteins to facilitate the fusion. Although the exact mechanism is unclear, SPESP1 indeed plays an important role in the process of fusion of a sperm with oocyte.

Cysteine-rich Secretory Protein 1 (CRISP1) is an Epididymal Protein Participating in the Fusion Process {#s5}
=======================================================================================================

The epididymal protein CRISP1, which is a member of the cysteine-rich secretory proteins (CRISPs) family, was identified as a sperm surface protein. Once the acrosome reaction occurs, CRISP1 migrates to the equatorial segment, where the sperm fuses with the oocyte plasma membrane \[[@r43]\]. At a structural level, CRISP1 contains a CAP domain, which has been implicated in cell-cell interactions. Coincubation of peptides derived from the CAP domain (amino acid residues 114--158) of rat CRISP1 reduced sperm-oocyte fusion during IVF \[[@r44]\]. IVF results indicated that *Crisp1*-deficient sperm show significant difficulty with penetration of the ZP and fusion with the oocyte plasma membrane \[[@r45]\]. These results suggest that CRISP1 participates in both ZP interaction and the sperm fusion with the oocyte. A similar epididymal protein was observed on human sperm and named AEG-related protein (ARP) \[[@r46],[@r47],[@r48]\]. It is also reported that human ARP plays a role in gamete fusion through complementary sites on the surface of the human oocyte.

Bactericidal/Permeability-increasing Protein (BPI) is a Novel Sperm Protein Involved in Sperm-oocyte Fusion {#s6}
===========================================================================================================

Recently, a novel sperm protein named bactericidal/permeability-increasing protein (BPI) has received a lot of attention. BPI is a 55--60 kDa single-chain cationic protein that belongs to a conserved family of lipid-transfer proteins. BPI can inhibit all the proinflammatory activities of lipopolysaccharides (LPS), including neutrophil oxidase enzyme activation, cytokine release, and nitric oxide formation \[[@r49]\]. In the male murine reproductive system, BPI was reported to be selectively expressed in testes and in the epididymis, not in the seminal vesicles, prostate, or solidification glands \[[@r50]\]. In our colleagues′ previous study, they discovered that mouse BPI is secreted by the epididymal epithelium and then localized to the surface of the sperm plasma membrane \[[@r51]\]. BPI is not expressed in the organs closer to the external environment; this finding suggests that BPI may have multiple functions in the male reproductive system not only the antimicrobial function in other organs. Furthermore, they found that BPI is enriched in the equatorial segment \[[@r51]\]. Thus, our colleagues and we are interested in the function of BPI in male infertility. Recent studies also implied that BPI may take part in the sperm-oocyte fusion process because incubation with anti-BPI antiserum reduces the number of sperm fused with oocytes significantly in an IVF assay \[[@r52], [@r53]\].

Taken together, these pieces of evidence indicate a dual origin of the BPI that is associated with mouse spermatozoa. This expression pattern of BPI is similar to that of some antimicrobial proteins, such as hCAP18/SOB3 localized both in the epididymal epithelia and within human spermatozoa acrosomes, potentially displaying zona pellucida-binding activity \[[@r54], [@r55]\]. Additionally, cystatin-related epididymal spermatogenic protein (CRESP) is reported to have both an antimicrobial function and a role in the sperm-oocyte fusion process \[[@r56], [@r57]\]. Due to the mutualism function of BPI in the interaction between proteins and microorganisms, it can be speculated that BPI on the sperm surface may not directly interact with the oocyte membrane but interacts with or regulates the function of some fusion-related proteins on the sperm surface such as CRESP, playing the role of a bridge molecule in the sperm-oocyte fusion process. This hypothesis requires more evidence and further testing.

Other Molecular Mechanisms Involved in Sperm-oocyte Fusion {#s7}
==========================================================

Cell-cell fusion
----------------

Although this review concentrates on molecules participating in gamete fusion, knowledge of the molecular mechanism underlying general cell-cell fusion could be truly useful. The cell-cell fusion mechanism remains poorly understood despite its physiological importance in the entire biological process. Recent related studies were focused on the discovery of fusogens: cell fusion proteins that bring the membranes closer together and mediate the mixing of bilayer membranes. In mammals, one family named syncytins has been reported as a well-defined fusogen. This family includes proteins that originate from endogenous retroviruses related to the HIV Gp41 envelope glycoprotein and function in the syncytial trophoblasts and in viral fusion \[[@r58]-[@r60]\]. For example, syncytin-1 was found to be expressed in the equatorial segment or acrosomal region of spermatozoa, while its receptor (ASCT-2) is expressed on oocytes; they together possibly participate in gamete fusion \[[@r61]\]. In a synaptic system, a family named SNAREs is also discovered as fusogens playing an important role in synaptic vesicles fusion process \[[@r62], [@r63]\]. In a sexual fusion system, it is hypothesized that sperm-oocyte fusion-related proteins, such as sperm IZUMO1, interact with fusogenic proteins on the sperm membrane or on the oocyte membrane to participate in the sperm-oocyte fusion. Sperm fusogens are thus expected to be located in the reproductive system and can function in cooperation with IZUMO1 or other molecules.

Besides the possibility of fusogenic proteins, it has been demonstrated that various adhesion molecules and enzymatic activities related to cell fusion are also involved in sperm-oocyte fusion because this process is in the category of cell-cell fusion processes. For adhesion molecules, cadherin is known as a human sperm protein. Cadherin is a transmembrane glycoprotein involved in calcium-dependent cell-cell adhesion events. An IVF assay indicated that anticadherin antibodies reduce the fusion of human sperm to a ZP-free hamster oocyte \[[@r64], [@r65]\]. Cadherin′s participation in gamete interaction has not been fully investigated. In addition, zinc metalloproteases are necessary for some intercellular fusion processes, such as cell-cell fusion in yeast. Inhibitors of zinc metalloproteases and zinc chelators are both found to reduce sperm-oocyte fusion. These observations indicate that a zinc metalloprotease may take part in the sperm-oocyte fusion process \[[@r66]\]. Research into the mechanisms on the basis of the studies of cell-cell fusion should bring new insights into the sperm-oocyte fusion process.

MicroRNAs
---------

MicroRNAs (miRNAs) are small noncoding single-stranded RNA molecules that are physiologically produced in eukaryotic cells to regulate or mostly downregulate genes by pairing with their complementary base sequence in relevant mRNA molecules in the cytoplasm. It has been reported that a dysfunction in miRNA processing such as the use of the Cre-LoxP system to create a specific mutant of sperm, Dorsha and Dicer, can result in azoospermia and infertility \[[@r67], [@r68]\]. Because of the necessity of single miRNA in target mRNA expression, targeted deletion of miRNA leads to a perceptible infertility phenotype in mice. Furthermore, in order to characterize the involvement of specific miRNAs that are highly expressed in the male reproductive system, several studies have been focused on miRNA function in this system. Double disruption of miR-34b/c and miR-449 miRNA clusters, which are highly expressed in testes, can cause dysregulation of more than 200 molecules and may lead to serious male and female infertility \[[@r69], [@r70]\]. In addition, recent evidence showed that miR-27b could negatively regulate the expression of CRISP2, which is involved in asthenozoospermia \[[@r71]\]. IVF studies showed that CRISP2 knockout sperm have a deficiency in penetration of the egg vestments (i.e., cumulus cells and ZP) and problems with fusion with the egg \[[@r72]\]. Based on these results, there is a greater possibility for miRNAs to take part in the sperm-oocyte fusion through regulation of the related proteins such as CRISP1, even though the exact function of miRNAs in the fusion needs further research. Reinforcing the role of miRNAs is identification of these molecules as potential therapeutic targets for the diagnosis and treatment of male infertility.

Due to the complex and important process of sperm-oocyte fusion in the sexual reproduction system, lots of molecules (that have the ability to participate in male infertility and were not elaborated exactly in this paper) have been summarized well in other reviews \[[@r73]\]. For example, sperm lysozyme-like protein (SLLP1), endoplasmic reticulum protein 29 (ERp29), and prostate and testis expression (PATE)-like proteins were reported to be involved in the sperm-oocyte interaction \[[@r74],[@r75],[@r76]\]. Disruption of these molecules can lead to a perceptible infertility phenotype in mice.

Conclusion {#s8}
==========

Sperm-oocyte fusion is one of the most impressive events in sexual reproduction, culminating in the merger of plasmatic membranes; the molecules involved in sperm-oocyte fusion on the sperm side are closely related to male infertility \[[@r77]\]. The elucidation of its molecular mechanism has confused scientists for a long time. This review highlighted the molecules participating in the sperm-oocyte fusion on the sperm side (summarized in [Table 1](#tbl_001){ref-type="table"}Table 1.Sperm molecules involved in sperm-oocyte fusionMoleculeMethodFusionReferenceADAM2Knockout\~ 50%\[[@r35], [@r36]\]α-L-FucosidaseAntibodies against α-L-FucosidaseReduced\[[@r78], [@r79]\]BPIAntibodies against BPIReduced\[[@r51]\]CalpainsAntibodies against CalpainsReduced\[[@r80]\]CRISP1KnockoutReduced\[[@r45]\]CRISP2KnockoutReduced\[[@r72]\]ERp29Antibodies against ERp29Reduced\[[@r75]\]IZUMO1KnockoutFailed\[[@r15]\]SLLP1Antibodies against SLLP1Reduced\[[@r76]\]SPACA6KnockoutFailed\[[@r81]\]SPESP1KnockoutSeverely reduced\[[@r39],[@r40],[@r41],[@r42]\]TSSK6KnockoutFailed\[[@r17]\]). Although many mechanisms for some molecules are to be refined and verified, this paper focused on the potential molecular mechanisms that may provide new ideas for clinical treatment of male infertility. Besides the molecules mentioned above, molecular mechanisms of the cell-cell fusion process such as formation of myotubes, placenta, multinucleated osteoclasts, and macrophages might be involved in the sperm reproduction system. This hypothesis needs to be tested by more experiments. Therefore, the focus on the role of sperm-oocyte fusion in male reproductive disorders can further elucidate the molecular mechanisms of male infertility and holds promise for identification of efficient biomarkers and therapeutic agents for these disorders. This study conclusively provides a novel insight into some of the mechanisms leading to sperm-oocyte fusion on the sperm side, offering a possible therapeutic target for treatment of male infertility or even for male contraception. We strongly believe that a combination of genetic, biochemical, and biophysical approaches will eventually identify and characterize these elusive proteins required for fertilization.
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